Diabetes - Diagnosis and Monitoring
Free shipping to and from you
Analyses the following
This home test checks your levels of HbA1c. This biomarker is used to confirm whether you have (or are at risk of developing) diabetes.
What can I expect from this Diabetes - Diagnosis and Monitoring?
This home test checks your levels of HbA1c. This biomarker is used to confirm whether you have (or are at risk of developing) diabetes. It is a potentially life-saving test and it is quite common for people have diabetes and not know about it. Unmanaged or undiagnosed diabetes is one of the leading causes of mortality. For anyone who already knows they have diabetes, regular HbA1c checks are essential to monitor progress.
Identifying conditions of this test
-
Diabetes
Diabetes (1 Biomarkers)
Checking your levels of HbA1c is a way of confirming if you have (or are at risk of developing) diabetes. Unmanaged or undiagnosed diabetes is one of the leading causes of mortality. For anyone who already knows they have diabetes, regular HbA1c checks are essential to monitor progress.
HbA1c (Glycosylated Haemoglobin)
Watch our 60 second video to learn more about Diabetes - Diagnosis and Monitoring blood test
How it works
Whether you use a home test or have your sample taken with one of our trained phlebotomists, our blood tests are quick and easy to use.
FAQs
What is a normal level?
A HbA1C level greater than 48mmol/mol carries a diagnosis of diabetes. A result between 42-47mmol/mol is considered high risk for diabetes.
Do I need to fast for this test?
No fasting is required.
Who should the test not be used on?
HbA1C levels should not be used to diagnose diabetes in the following groups: • Children and young people less than 18 years of age. • Pregnant women or women who are 2 months postpartum. • People with symptoms of diabetes for less than 2 months. • People at high diabetes risk who are acutely ill. • People taking medication that may cause hyperglycaemia (for example long-term corticosteroid treatment). • People with acute pancreatic damage. • People with end-stage renal disease (ESRD). • People with HIV infection. • People with chronic haemolytic anaemia.
Trusted by
